Streetbeat News

Stock Prices

BCRX

BioCryst Pharma (NASDAQ:BCRX) has received updated analyst ratings in the last quarter, with 1 bullish and 3 somewhat bullish ratings. The average 12-month price target for BCRX is $10.5, with a high of $12.00 and a low of $10.00, marking a 16.67% increase from the previous target of $9.00. Analysts base their ratings on financial predictions and company performance metrics.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

UNH

Analysts have recently rated UnitedHealth Group (NYSE:UNH) with 1 bullish, 4 somewhat bullish, and 3 indifferent ratings. The average price target is $570.5, representing an upside from the current price of $534.02. This target has increased by 0.69% from the previous target of $566.60. Analyst ratings are based on predictions of a company's future earnings and revenue, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

CABO

CHTR

CMCSA

DISH

A comparative study evaluates Comcast (NASDAQ:CMCSA) against its peers in the Media industry, analyzing financial metrics and market position. Comcast's P/E, P/B, and P/S ratios, ROE, EBITDA, gross profit, and revenue growth are compared to Charter Communications Inc, Cable One Inc, and DISH Network Corp. Comcast's P/E and P/B ratios suggest undervaluation, while its P/S ratio indicates potential overvaluation. The company's ROE, EBITDA, gross profit, and revenue growth are strong, indicating robust performance and market outperformance.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

CHTR

Charter Communications (NASDAQ:CHTR) is evaluated against its competitors in the Media industry. It has a lower P/E ratio, suggesting growth potential, but a higher P/B ratio, indicating it may be overvalued in terms of book value. Its P/S ratio is below the industry average, suggesting it's undervalued based on sales. CHTR has a higher ROE and EBITDA than its peers, indicating efficient profit generation and strong cash flow. Revenue growth is positive compared to a negative industry average, showing market share gains. However, its gross profit is below the industry average, and it has a high debt-to-equity ratio, which could signal financial risk.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

QS

QuantumScape (NYSE:QS) has received mixed analyst ratings in the last quarter, with an average 12-month price target of $7.00, representing a 12.5% decrease from the previous target of $8.00. Ratings include 1 somewhat bullish, 2 indifferent, and 1 bearish. Analysts provide these ratings based on financial analysis and company insights, and they are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

MRVL

Marvell Tech (NASDAQ:MRVL) has delivered an average annual return of 14.6% over the past 10 years, outperforming the market by 4.99% annually. A $100 investment in MRVL a decade ago would be worth $385.01 today. The company's current market capitalization stands at $48.10 billion.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

PENN

Analysts have recently rated PENN Entertainment (NASDAQ:PENN) with 3 bullish and 5 indifferent ratings. The average price target is $27.25, which is 5.37% above the current price of $25.86. This target has decreased by 8.16% from the previous target of $29.67. Analyst ratings are provided quarterly and are based on financial analysis and insider information.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

TXN

Texas Instruments (NASDAQ:TXN) has delivered an average annual return of 8.59% over the past 20 years, outperforming the market by 1.09% annually. A $100 investment in TXN stock 20 years ago would be worth $521.89 today. The company's current market capitalization stands at $140.55 billion.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

CDW

CDW (NASDAQ:CDW) is evaluated against competitors in the Electronic Equipment, Instruments & Components industry. CDW shows a premium valuation with higher P/E, P/B, and P/S ratios than the industry average. Its ROE, EBITDA, and gross profit are significantly above the industry average, indicating strong profitability and cash flow. However, CDW's revenue growth is below the industry average, and it has a high debt-to-equity ratio, suggesting financial risk and slower sales growth.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

GTEC

Greenland Technologies Holding Corp (GTEC) shares dropped over 12% after reporting Q3 FY23 results with revenue of $21.84 million, missing the consensus estimate of $24.27 million. The company sold more transmission products compared to the previous year and saw a 30.3% increase in gross profit, with a higher gross margin due to a shift towards higher value products. However, GTEC reported an EPS loss of $(0.07), which was below the expected $0.06 EPS. Despite challenges, the company has $21.54 million in cash and equivalents as of September 30, 2023.

Portfolio Pulse from Lekha Gupta

November 20, 2023 | 4:00 pm